The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Linear muscle segmentation for metastatic renal cell carcinoma.
 
Edouard Nicaise
No Relationships to Disclose
 
Benjamin Schmeusser
No Relationships to Disclose
 
Adil Ali
No Relationships to Disclose
 
Eric Midenberg
No Relationships to Disclose
 
Arnold Raul Palacios
No Relationships to Disclose
 
Ethan Kearns
No Relationships to Disclose
 
Sriram Ambadi
No Relationships to Disclose
 
Dattatraya H. Patil
No Relationships to Disclose
 
Shreyas S. Joshi
No Relationships to Disclose
 
Vikram M Narayan
Consulting or Advisory Role - Ferring Ventures; Merck
Research Funding - Photocure
 
Sarah P. Psutka
Honoraria - AstraZeneca
Consulting or Advisory Role - Janssen; Merck
Travel, Accommodations, Expenses - medtronic
 
Bassel Nazha
Honoraria - Intellisphere, LLC (Onclive)
Consulting or Advisory Role - Cardinal Health; Exelixis; IntrinsiQ
 
Jacqueline T Brown
Honoraria - Curio/Vaniam Group
Research Funding - Medicenna (Inst); Surface Oncology (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - Curio/Vaniam Group
 
Kenneth Ogan
No Relationships to Disclose
 
Mehmet Asim Bilen
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Calithera Biosciences; Eisai; EMD Serono; Exelixis; Exelixis; Genomic Health; Janssen; Nektar; Pfizer; Sanofi; SeaGen
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genentech/Roche (Inst); Genome & Company (Inst); Incyte (Inst); Merck (Inst); Nektar (Inst); NiKang Therapeutics (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Seagen (Inst); Tricon Pharmaceuticals (Inst); Xencor (Inst)
 
Viraj A. Master
Honoraria - Ethicon; Exelixis